Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen-associated carbohydrate moieties are not a single molecule or receptor, but rather diverse carbohydrate structures or motifs displayed on the surfaces of pathogenic organisms (such as bacteria, protozoa, fungi, and viruses) that are involved in host-pathogen interactions and immune recognition[1][2][3][5]. They are typically not named as a specific canonical molecular entity. Pathogen-associated carbohydrate moieties refer to the various carbohydrate structures present on the surfaces of pathogens, including glycoproteins, glycolipids, polysaccharides, and other glycans[1][2][3]. These moieties are recognized by the host immune system and are critical for pathogen attachment, invasion, immune evasion (such as molecular mimicry), and induction of immune responses. They play essential roles in the biology and pathogenicity of many infectious agents, and are targeted by both natural and adaptive immune mechanisms[1][2][3]. Examples include capsular polysaccharides of bacteria, glycosylphosphatidylinositol anchors in protozoa, and sialylated structures mimicking host glycans[1][2][3]. These moieties are not universally well-conserved, making them useful but sometimes challenging targets for vaccine and drug development[3]. Host receptors (including lectins, Toll-like receptors, and natural antibodies) recognize these carbohydrate structures, leading to immune activation or tolerance[1][2][3]. Pathogens may modify their surface carbohydrate patterns as an immune evasion strategy, sometimes mimicking host structures (e.g., sialic acid capsules, Lewis antigen mimicry)[2]. In summary, “Pathogen-associated carbohydrate moiety” is a broad structural class rather than a specific, individual therapeutic target. It encompasses a wide variety of carbohydrate-containing structures important for pathogen biology and immune recognition, and is essential in infectious disease, immunology, and vaccine research[1][2][3][4][5].
Induction of protective immunity via antibody or T-cell response to carbohydrate epitopes; Blocking of pathogen adhesion to host cells (by antibody or synthetic molecule); Targeting molecular mimicry to break immune tolerance
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen-associated carbohydrate moiety (null).